@article{cb731b85b9194b8b90bb56b4cdf19db8,
title = "Discussion of lung adenocarcinoma effectively treated with erlotinib: A case investigation",
abstract = "Introduction: The current reality is that the usage of gefitinib and erlotinib, two molecularly targeted drugs to treat advanced non-small cell lung cancer, has not been clearly delineated. Here, we report a case of lung adenocarcinoma in which the patient developed resistance to gefitinib but later erlotinib therapy proved to be effective. Discussion: Erlotinib is an oral agent and is also beneficial in terms of QOL.",
keywords = "Erlotinib, Lung cancer, Molecularly targeted drug",
author = "Yoshitsugu Fujita and Masamichi Mineshita and Hirotaka Kida and Hiroshi Handa and Fuzuki Ishikawa and Masahiro Oshige and Teruomi Miyazawa and Kenji Eguchi and Nobuhiko Seki and Ken Inoue",
year = "2010",
month = sep,
language = "英語",
volume = "17",
pages = "236--237",
journal = "International Medical Journal",
issn = "1341-2051",
publisher = "Japan International Cultural Exchange Foundation",
number = "3",
}
